EN SV

Nomination Committee

Nomination Committee

Not later than the end of the third quarter every year the three largest shareholders or groups of shareholders in terms of the number of votes they hold shall be given the opportunity to appoint a member to the Election Committee. The Board Chairman shall be a member of the Election Committee.

The names of the committee's members are to be publicly announced not later than six months prior to the Annual General Meeting.
The composition of the Nominating Committee for the 2027 Annual General Meeting was made public on November 3, 2026:

  • Niels Jacobsen, appointed by William Demant Invest A/S
  • Patrik Tigerschiöld, appointed by Bure Equity AB
  • Rikke Reinemo, appointed by Ferd AS
  • Jón Sigurdsson, Chairman of the Board

The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vitrolife AB on May 5, 2026. The Election Committee shall prepare and present proposals for resolution by the Annual General Meeting regarding:

  • election of a Chairman of the meeting,
  • decision on the number of Board members,
  • election of and decision on remuneration to the Board Chairman and other members of the Board
  • election of and decision on remuneration to the auditor and deputy auditor (when appropriate)
  • election of and decision on remuneration to the members of the Board regarding any special - committees as the Annual General Meeting may decide to appoint,

The Annual General Meeting will be held in Gothenburg on 4 May 2027. Shareholders wishing to have matters considered at the Annual General Meeting should submit their proposals in writing to [email protected] or to Vitrolife AB (publ), Attn: Chairman of the Board, P. O. Box 9080, SE-400 92 Gothenburg, Sweden, at least seven weeks before the Annual General Meeting, in order for the proposal to be included in the notice of the Annual General Meeting. 

Related Files

Establishment of election committee 2026-2027

clinical-result

Financial Reports

Read Vitrolife Group's financial reports, including the latest release of the annual and sustainability report and interim reports.

Read our latest financial reports
customer-offer

Sustainability

Ensuring sustainability in everything we do is one of our key strategic priorities. Learn more on our approach and sustainability themes.

Find out more
clinical-result

Corporate governance

Vitrolife AB is a publicly traded Swedish company listed on NASDAQ Stockholm. The company's corporate governance policies comply with Swedish laws and regulations.

Find out more